Exome sequencing and characterization of 49,960 individuals in the UK Biobank.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
10 2020
Historique:
received: 14 03 2019
accepted: 25 08 2020
pubmed: 23 10 2020
medline: 3 2 2021
entrez: 22 10 2020
Statut: ppublish

Résumé

The UK Biobank is a prospective study of 502,543 individuals, combining extensive phenotypic and genotypic data with streamlined access for researchers around the world

Identifiants

pubmed: 33087929
doi: 10.1038/s41586-020-2853-0
pii: 10.1038/s41586-020-2853-0
pmc: PMC7759458
doi:

Substances chimiques

Col6a1 protein, human 0
Collagen Type VI 0
IQGAP2 protein, human 0
Ion Channels 0
MEPE protein (242-264), human 0
PIEZO1 protein, human 0
Peptide Fragments 0
ras GTPase-Activating Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

749-756

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Genet Med. 2018 Apr;20(5):554-558
pubmed: 29261187
JAMA Cardiol. 2017 Aug 1;2(8):882-889
pubmed: 28678979
N Engl J Med. 2017 Jul 20;377(3):211-221
pubmed: 28538136
Nat Commun. 2018 Apr 24;9(1):1613
pubmed: 29691411
Cell. 2016 Nov 17;167(5):1415-1429.e19
pubmed: 27863252
Nat Commun. 2017 Dec 13;8(1):2108
pubmed: 29235454
Platelets. 2016 Sep;27(6):519-25
pubmed: 27025194
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Nat Commun. 2015 Sep 03;6:8085
pubmed: 26333996
Leukemia. 2009 Nov;23(11):2183-6
pubmed: 19609284
Genet Med. 2017 Feb;19(2):249-255
pubmed: 27854360
Int J Epidemiol. 2013 Aug;42(4):968-77
pubmed: 22879362
Hum Mutat. 2013 Mar;34(3):490-7
pubmed: 23255516
Nat Genet. 2012 Apr 15;44(5):491-501
pubmed: 22504420
Genet Med. 2013 Jul;15(7):565-74
pubmed: 23788249
J Proteomics. 2013 Jul 11;87:122-31
pubmed: 23727491
FEBS Lett. 1986 Mar 3;197(1-2):55-8
pubmed: 3512309
Nat Genet. 2005 Feb;37(2):161-5
pubmed: 15654334
J Clin Oncol. 2007 Apr 10;25(11):1329-33
pubmed: 17416853
PLoS Genet. 2019 Apr 18;15(4):e1008110
pubmed: 30998689
Cell. 2002 Jan 25;108(2):171-82
pubmed: 11832208
N Engl J Med. 2018 Mar 22;378(12):1096-1106
pubmed: 29562163
N Engl J Med. 2006 Mar 23;354(12):1264-72
pubmed: 16554528
Science. 2016 Dec 23;354(6319):
pubmed: 28008010
J Am Soc Nephrol. 2005 Jun;16(6):1645-53
pubmed: 15843468
PLoS Genet. 2017 Mar 8;13(3):e1006659
pubmed: 28273074
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Am J Hum Genet. 2014 Nov 6;95(5):553-64
pubmed: 25439724
Sci Transl Med. 2016 Jun 1;8(341):341ra76
pubmed: 27252175
N Engl J Med. 2014 Aug 7;371(6):497-506
pubmed: 25099575
Nature. 2014 Nov 13;515(7526):279-282
pubmed: 25119035
Nat Genet. 2016 Jul;48(7):709-17
pubmed: 27182965
Genet Epidemiol. 2010 Dec;34(8):816-34
pubmed: 21058334
ISRN Ophthalmol. 2014 Mar 04;2014:724546
pubmed: 24729900
N Engl J Med. 2005 Sep 15;353(11):1135-46
pubmed: 16162884
Science. 2016 Dec 23;354(6319):
pubmed: 28008009
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3199-202
pubmed: 19255149
Blood. 2010 Oct 14;116(15):2627-34
pubmed: 20610812
Bioinformatics. 2019 Jul 15;35(14):2495-2497
pubmed: 30520965
Blood. 2017 Jan 26;129(4):520-524
pubmed: 28064200
Nature. 2015 Feb 5;518(7537):102-6
pubmed: 25487149
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Annu Rev Med. 2012;63:35-61
pubmed: 22248320
Nat Rev Endocrinol. 2016 Oct;12(10):593-605
pubmed: 27230951
Int J Epidemiol. 2020 Feb 1;49(1):20-21i
pubmed: 31504546
Science. 2012 Feb 17;335(6070):823-8
pubmed: 22344438
Am J Hum Genet. 2016 Jul 7;99(1):40-55
pubmed: 27346686
Int J Nephrol Renovasc Dis. 2010;3:69-83
pubmed: 21694932
Nat Genet. 2002 May;31(1):55-9
pubmed: 11967536
Kidney Int. 2003 Feb;63(2):447-53
pubmed: 12631110
J Biol Chem. 2003 Jan 17;278(3):1998-2007
pubmed: 12421822
BMJ. 2016 Mar 08;352:i582
pubmed: 26956984
Am J Hum Genet. 2006 Mar;78(3):510-9
pubmed: 16465624
Bone. 2015 Oct;79:131-42
pubmed: 26051469
N Engl J Med. 2012 Feb 16;366(7):619-28
pubmed: 22335739
Nat Genet. 2007 Jul;39(7):906-13
pubmed: 17572673
JAMA Netw Open. 2018 Sep 7;1(5):e182140
pubmed: 30646163
Nature. 2017 Apr 12;544(7649):235-239
pubmed: 28406212

Auteurs

Cristopher V Van Hout (CV)

Regeneron Genetics Center, Tarrytown, NY, USA. cristopher.vanhout@regeneron.com.

Ioanna Tachmazidou (I)

GlaxoSmithKline, Stevenage, UK.
AstraZeneca, Cambridge, UK.

Joshua D Backman (JD)

Regeneron Genetics Center, Tarrytown, NY, USA.

Joshua D Hoffman (JD)

GlaxoSmithKline, Collegeville, PA, USA.
Foresite Labs, Cambridge, MA, USA.

Daren Liu (D)

Regeneron Genetics Center, Tarrytown, NY, USA.

Ashutosh K Pandey (AK)

GlaxoSmithKline, Collegeville, PA, USA.

Claudia Gonzaga-Jauregui (C)

Regeneron Genetics Center, Tarrytown, NY, USA.

Shareef Khalid (S)

Regeneron Genetics Center, Tarrytown, NY, USA.

Bin Ye (B)

Regeneron Genetics Center, Tarrytown, NY, USA.

Nilanjana Banerjee (N)

Regeneron Genetics Center, Tarrytown, NY, USA.

Alexander H Li (AH)

Regeneron Genetics Center, Tarrytown, NY, USA.

Colm O'Dushlaine (C)

Regeneron Genetics Center, Tarrytown, NY, USA.

Anthony Marcketta (A)

Regeneron Genetics Center, Tarrytown, NY, USA.

Jeffrey Staples (J)

Regeneron Genetics Center, Tarrytown, NY, USA.

Claudia Schurmann (C)

Regeneron Genetics Center, Tarrytown, NY, USA.
Digital Health Center, Hasso Plattner Institute, University of Potsdam, Potsdam, Germany.
Hasso Plattner Institute for Digital Health at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Alicia Hawes (A)

Regeneron Genetics Center, Tarrytown, NY, USA.

Evan Maxwell (E)

Regeneron Genetics Center, Tarrytown, NY, USA.

Leland Barnard (L)

Regeneron Genetics Center, Tarrytown, NY, USA.

Alexander Lopez (A)

Regeneron Genetics Center, Tarrytown, NY, USA.

John Penn (J)

Regeneron Genetics Center, Tarrytown, NY, USA.
DNANexus, Mountain View, CA, USA.

Lukas Habegger (L)

Regeneron Genetics Center, Tarrytown, NY, USA.

Andrew L Blumenfeld (AL)

Regeneron Genetics Center, Tarrytown, NY, USA.

Xiaodong Bai (X)

Regeneron Genetics Center, Tarrytown, NY, USA.

Sean O'Keeffe (S)

Regeneron Genetics Center, Tarrytown, NY, USA.

Ashish Yadav (A)

Regeneron Genetics Center, Tarrytown, NY, USA.

Kavita Praveen (K)

Regeneron Genetics Center, Tarrytown, NY, USA.

Marcus Jones (M)

Regeneron Pharmaceuticals, Tarrytown, NY, USA.

William J Salerno (WJ)

Regeneron Genetics Center, Tarrytown, NY, USA.

Wendy K Chung (WK)

Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, USA.
Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Ida Surakka (I)

University of Michigan, Ann Arbor, MI, USA.

Cristen J Willer (CJ)

University of Michigan, Ann Arbor, MI, USA.

Kristian Hveem (K)

Norwegian University of Science and Technology, Trondheim, Norway.

Joseph B Leader (JB)

Geisinger, Dannville, PA, USA.

David J Carey (DJ)

Geisinger, Dannville, PA, USA.

Lon Cardon (L)

GlaxoSmithKline, Stevenage, UK.

George D Yancopoulos (GD)

Regeneron Pharmaceuticals, Tarrytown, NY, USA.

Aris Economides (A)

Regeneron Pharmaceuticals, Tarrytown, NY, USA.

Giovanni Coppola (G)

Regeneron Genetics Center, Tarrytown, NY, USA.

Alan R Shuldiner (AR)

Regeneron Genetics Center, Tarrytown, NY, USA.

Suganthi Balasubramanian (S)

Regeneron Genetics Center, Tarrytown, NY, USA.

Michael Cantor (M)

Regeneron Genetics Center, Tarrytown, NY, USA.

Matthew R Nelson (MR)

GlaxoSmithKline, Collegeville, PA, USA.
Deerfield, New York, NY, USA.

John Whittaker (J)

GlaxoSmithKline, Stevenage, UK.

Jeffrey G Reid (JG)

Regeneron Genetics Center, Tarrytown, NY, USA.

Jonathan Marchini (J)

Regeneron Genetics Center, Tarrytown, NY, USA.

John D Overton (JD)

Regeneron Genetics Center, Tarrytown, NY, USA.

Robert A Scott (RA)

GlaxoSmithKline, Stevenage, UK. robert.a.scott@gsk.com.

Gonçalo R Abecasis (GR)

Regeneron Genetics Center, Tarrytown, NY, USA.

Laura Yerges-Armstrong (L)

GlaxoSmithKline, Collegeville, PA, USA. laura.m.yerges-armstrong@gsk.com.

Aris Baras (A)

Regeneron Genetics Center, Tarrytown, NY, USA. aris.baras@regeneron.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH